Table 2.
Univariable | Multivariable | |||
---|---|---|---|---|
PHQ-9 mean difference (95% CI) | p-value | PHQ-9 mean difference (95% CI) | p-value | |
Age | − 0.05 (− 0.01 to 0.008) | 0.096 | NS | |
Sex (male) | 0.64 (− 1.4 to 2.70) | 0.537 | ||
CD4, every 100 cells/μl | − 0.03 (− 0.2 to 0.2) | 0.713 | ||
Viral suppression | − 3.4 (− 5.7 to − 1.2) | 0.003 | − 3.2 (− 0.9 to − 5.4) | 0.006 |
PHQ-9 ≥ 10 before DTG | − 2.8 (− 4.3 to − 1.3) | < 0.001 | − 2.7 (− 1.2 to − 4.2) | < 0.001 |
PHQ-9 ≥ 15 before DTG | − 6.2 (− 8.6 to − 3.7) | < 0.001 | ||
EFV use before DTG | 0.11 (− 1.1 to 1.3) | 0.859 |
PHQ-9 change = PHQ-9 at 2nd assessment minus PHQ-9 at 1st assessment
Statistical method: Linear regression with PHQ-9 change as dependent variable
Factors with p < 0.1 in the univariable model were included into multivariable analysis
NS not significant, PHQ-9 Patient Health Questionnaire-9, EFV Efavirenz